Lb Pharmaceuticals (LBRX)10% owner bought ~$4.99M
Vida Ventures GP III, 10% owner at Lb Pharmaceuticals, bought ~$4.99M of Lb Pharmaceuticals shares.
- ~$4.99M
- Approx. value · 333K sh @ $15.00
- 880K
- Holds after · shares reported
- Traded
- Sep 12, 2025
- Filed
- Sep 16, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 12, 2025 · this disclosureInsider10% owner purchased ~$4.99M of LBRX shares in the open market
What came next
- Sep 12, 2025Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Sep 12, 2025Insider · 4 peopleInsiders: 5 purchases (~$70.0M)
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 10, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Lb Pharmaceuticals
OQRO holds no insider, Congress, fund or contract record for Lb Pharmaceuticals dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LBRX page.
Other recent filings by Vida Ventures GP III, L.L.C., 10% owner
The full history of Vida Ventures GP III, L.L.C., 10% owner is on the profile page.
How this filing works
Other disclosures at Lb Pharmaceuticals
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRNov 14, 2025
- SEC Form 4Sep 16, 2025
- SEC Form 4Sep 16, 2025
- SEC Form 4Sep 16, 2025
Everything OQRO holds on this company is on its LBRX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data